| SECTION I | GENERAL PRINCIPLES |
| Question 1 | How Frequently Does Blindness Develop Among Patients With Primary Open-Angle Glaucoma? With Ocular Hypertension?
Philip P. Chen, MD |
| Question 2 | Does Reducing Intraocular Pressure Really Prevent Development and Progression of Glaucoma?
Kuldev Singh, MD, MPH |
| Question 3 | What Are the Most Frequent Causes of Glaucoma-Related Medical Malpractice Suits? What Can I Do to Minimize My Risk?
E. Randy Craven, MD |
| | |
| SECTION II | GLAUCOMA DIAGNOSIS |
| Question 4 | How Should I Clinically Examine the Optic Nerve?
Felipe A. Medeiros, MD, PhD |
| Question 5 | Which Imaging Device Should I Use in My Practice?
Christopher A. Girkin, MD, MSPH, FACS |
| Question 6 | Is There Still a Role for Stereo Disc Photography in the Diagnosis and Management of Glaucoma?
Paul J. Mackenzie, MD, PhD (co-authored with George A. Cioffi, MD) |
| Question 7 | What Visual Field Tests Should I Use in My Glaucoma Suspects? In My Patients With Manifest Glaucoma?
Chris A. Johnson, PhD |
| Question 8 | What Is the Best Method for Detecting Glaucoma Development? Glaucomatous Progression?
Balwantray C. Chauhan, PhD |
| Question 9 | What Are the Implications of Disc Hemorrhages in Glaucoma Patients or Suspects?
Jody R. Piltz-Seymour, MD |
| Question 10 | How Should I Follow Patients With Anomalous Optic Discs, Such as Those With Optic Nerve Drusen, Tilted Discs, Myopic Discs, and Discs With Pits?
Jane Loman, MD (co-authored with Joseph Caprioli, MD) |
| Question 11 | How Is 24-Hour Intraocular Pressure Assessed? Is It Important in Glaucoma Management or Risk Assessment?
Robert N. Weinreb, MD (co-authored with John H.K. Liu, PhD) |
| Question 12 | Should I Measure Central Corneal Thickness in All Glaucoma Patients? All Glaucoma Suspects?
James D. Brandt, MD |
| Question 13 | How Frequently Should I Perform Follow-Up Examinations, Gonioscopy, Visual Field Testing, and Optic Nerve Evaluation in Glaucoma Patients?
Dana M. Blumberg, MD (co-authored with Paul P. Lee, MD) |
| Question 14 | In Which Patients With Glaucoma Should I Perform Neuroimaging, Cardiovascular Evaluation, and/or Laboratory Testing?">
David S. Greenfield, MD |
| Question 15 | When Should I Suspect Nonpupillary Block Secondary Angle-Closure? What Are the Causes?
Angelo P. Tanna, MD |
| Question 16 | What Systemic Diseases Can Be Associated With Glaucoma?
M. Bruce Shields, MD |
| | |
| SECTION III | GENERAL MANAGEMENT |
| Question 17 | Which Patients With Ocular Hypertension Should I Treat?
Husam Ansari, MD, PhD (co-authored with Richard K. Parrish II, MD) |
| Question 18 | How Should I Set a Target Intraocular Pressure?
Gregg A. Heatley, MD |
| Question 19 | How Should I Begin Treatment for a Newly Diagnosed Primary Open-Angle Glaucoma Patient?
Annisa L. Jamil, MD (co-authored with Richard P. Mills, MD, MPH) |
| Question 20 | Are There Special Issues of Which I Should Be Aware Regarding Pigment Dispersion Syndrome or Pigmentary Glaucoma?
Celso Tello, MD (co-authored with Robert Ritch, MD) |
| Question 21 | Does Exfoliation Syndrome Increase the Risk of Developing Glaucoma? Are Patients With Exfoliation Glaucoma More Likely to Progress? What Other Issues Do These Patients Have?
Robert Ritch, MD |
| Question 22 | How Frequent Is Corticosteroid-Induced Glaucoma? How Should I Manage It?
Davinder S. Grover, MD, MPH (co-authored with Alan L. Robin, MD) |
| Question 23 | What Methods Are Available to Break an Acute Attack of Angle-Closure Glaucoma?
Darrell WuDunn, MD, PhD |
| Question 24 | How Should I Manage Neovascular Glaucoma?
Hylton R. Mayer, MD (co-authored with James C. Tsai, MD) |
| Question 25 | How Should I Treat Elevated Intraocular Pressure (With or Without Glaucoma Damage) Associated With Uveitis?
David Cute, DO (co-authored with Francisco Fantes, MD) |
| Question 26 | What Treatment Options Are Available for a Blind, Painful Eye?
Jonathan S. Myers, MD |
| | |
| SECTION IV | MEDICAL THERAPY |
| Question 27 | Is a Unilateral Trial Useful When Starting Treatment With a Glaucoma Medication?
Angelo P. Tanna, MD (co-authored with Theodore Krupin, MD) |
| Question 28 | Which Glaucoma Medications Should Be Used as Initial Therapy?
Steven L. Mansberger, MD, MPH |
| Question 29 | What Is Maximum Medical Therapy in Glaucoma Management?
Simon K. Law, MD, PharmD |
| Question 30 | Which Glaucoma Medications Can Be Safely Used During Pregnancy? In Childhood?
Bhavna P. Sheth, MD |
| Question 31 | Is There Still a Role for Miotics in Some Patients? Oral Carbonic Anhydrase Inhibitors?
Richard K. Lee, MD, PhD |
| Question 32 | How Should I Treat the Glaucoma Patient With Topical Drug Allergies?
Jess T. Whitson, MD |
| Question 33 | How Can I Improve Patient Adherence?
Silvia Orengo-Nania, MD |
| | |
| SECTION V | LASER AND INCISIONAL GLAUCOMA SURGERY |
| Question 34 | When Should I Perform Laser Trabeculoplasty in My Patients With Open-Angle Glaucoma?
L. Jay Katz, MD (co-authored with Scott J. Fudemberg, MD) |
| Question 35 | When Should I Perform a Prophylactic Laser Iridotomy?
Martin Wand, MD |
| Question 36 | When Is Laser Iridoplasty Used?
Jeffrey M. Liebmann, MD |
| Question 37 | When Is Incisional Glaucoma Surgery Indicated?
Annette Giangiacomo, MD (co-authored with Anne Louise Coleman, MD, PhD) |
| Question 38 | What Can I Do to Reduce the Risks of Complications and Failure After Trabeculectomy?
Mark Sherwood, FRCP, FRCS, FRCOphth |
| Question 39 | What Can I Do After Trabeculectomy to Improve Its Success Rate?
Martha M. Wright, MD |
| Question 40 | How Do I Manage Chronic Hypotony Maculopathy? How Soon Should I Intervene?
Paul Palmberg, MD, PhD |
| Question 41 | What Are Causes of Anterior Chamber Shallowing After Trabeculectomy?
Paul A. Sidoti, MD |
| Question 42 | How Should I Manage a Late-Onset Bleb Leak?
Donald L. Budenz, MD, MPH |
| Question 43 | What Factors Increase the Risk of Bleb-Related Infection? How Should I Treat Blebitis and Bleb-Related Endophthalmitis If It Develops?
Richard M. Awdeh, MD (co-authored with Leon W. Herndon, MD
and Terry Kim, MD) |
| Question 44 | In Which Patients With Glaucoma and Cataracts Should I Perform a Combined Procedure? Cataract Surgery Alone? Trabeculectomy First?
Bradford J. Shingleton, MD |
| Question 45 | What Are the Indications for Placement of an Aqueous Shunt?
Don Minckler, MD, MS |
| Question 46 | What Is the Best Surgical Approach for Managing Uncontrolled Glaucoma in a Patient Who Had Previous Cataract Extraction or Failed Filtering Surgery?
Steven J. Gedde, MD |
| Question 47 | Is There a Role for Nonpenetrating Glaucoma Surgery?
Richard A. Lewis, MD |
| Question 48 | What Other New Surgical Techniques Are Available for Glaucoma?
Peter A. Netland, MD, PhD |
| Question 49 | In Which Glaucoma Patients Should I Consider Cyclodestruction?
Malik Y. Kahook, MD |